TY - JOUR
T1 - Association between fibrinogen and carotid atherosclerosis according to smoking status in a Korean male population
AU - Cho, Hye Min
AU - Kang, Dae Ryong
AU - Kim, Hyeon Chang
AU - Oh, Sun Min
AU - Kim, Byeong Keuk
AU - Suh, Il
N1 - Publisher Copyright:
© Yonsei University College of Medicine 2015.
PY - 2015/7/1
Y1 - 2015/7/1
N2 - Purpose: Although inconsistent, reports have shown fibrinogen levels to be associated with atherosclerosis. Accordingly, since cigarette smoking is associated with increased levels of fibrinogen and atherosclerosis, it may also affect the association between fibrinogen and atherosclerosis. We investigated the associations between fibrinogen and carotid intima-media thickness (IMT) according to smoking status in a Korean male population. Materials and Methods: Plasma fibrinogen levels were measured in 277 men aged 40‒87 years without a history of myocardial infarction or stroke. High-resolution B-mode ultrasonography was used to examine the common carotid arteries. IMT level was analyzed both as a continuous (IMT-max, maximum value; IMT-tpm, 3-point mean value) and categorical variable (higher IMT; presence of plaque). Serial linear and logistic regression models were employed to examine the association between fibrinogen and IMT according to smoking status. Results: Fibrinogen levels were positively associated with IMT-max (standardized β=0.25, p=0.021) and IMT-tpm (standardized β=0.21, p=0.038), even after adjusting for age, body mass index, systolic blood pressure, fasting glucose, and total cholesterol to high-density lipoprotein cholesterol ratio in current smokers (n=75). No significant association between fibrinogen and IMT, however, was noted in former smokers (n=80) or nonsmokers (n=122). Adjusted odds ratios (95% confidence interval) for having plaque per one standard deviation higher fibrinogen level were 2.06 (1.09‒3.89) for current smokers, 0.68 (0.43‒1.10) for former smokers, and 1.06 (0.60‒1.87) for nonsmokers. Conclusion: Our findings suggest that cigarette smoking may modify the association between fibrinogen and carotid atherosclerosis. Further studies are required to confirm this finding in different populations.
AB - Purpose: Although inconsistent, reports have shown fibrinogen levels to be associated with atherosclerosis. Accordingly, since cigarette smoking is associated with increased levels of fibrinogen and atherosclerosis, it may also affect the association between fibrinogen and atherosclerosis. We investigated the associations between fibrinogen and carotid intima-media thickness (IMT) according to smoking status in a Korean male population. Materials and Methods: Plasma fibrinogen levels were measured in 277 men aged 40‒87 years without a history of myocardial infarction or stroke. High-resolution B-mode ultrasonography was used to examine the common carotid arteries. IMT level was analyzed both as a continuous (IMT-max, maximum value; IMT-tpm, 3-point mean value) and categorical variable (higher IMT; presence of plaque). Serial linear and logistic regression models were employed to examine the association between fibrinogen and IMT according to smoking status. Results: Fibrinogen levels were positively associated with IMT-max (standardized β=0.25, p=0.021) and IMT-tpm (standardized β=0.21, p=0.038), even after adjusting for age, body mass index, systolic blood pressure, fasting glucose, and total cholesterol to high-density lipoprotein cholesterol ratio in current smokers (n=75). No significant association between fibrinogen and IMT, however, was noted in former smokers (n=80) or nonsmokers (n=122). Adjusted odds ratios (95% confidence interval) for having plaque per one standard deviation higher fibrinogen level were 2.06 (1.09‒3.89) for current smokers, 0.68 (0.43‒1.10) for former smokers, and 1.06 (0.60‒1.87) for nonsmokers. Conclusion: Our findings suggest that cigarette smoking may modify the association between fibrinogen and carotid atherosclerosis. Further studies are required to confirm this finding in different populations.
UR - http://www.scopus.com/inward/record.url?scp=84931048525&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84931048525&partnerID=8YFLogxK
U2 - 10.3349/ymj.2015.56.4.921
DO - 10.3349/ymj.2015.56.4.921
M3 - Article
C2 - 26069112
AN - SCOPUS:84931048525
SN - 0513-5796
VL - 56
SP - 921
EP - 927
JO - Yonsei medical journal
JF - Yonsei medical journal
IS - 4
ER -